Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Identification of receptor-type protein tyrosine phosphatase μ as a new marker for osteocytes.

de Rooij KE, van der Velde M, de Wilt E, Deckers MM, Bezemer M, Waarsing JH, Que I, Chan AB, Kaijzel EL, Löwik CW.

Histochem Cell Biol. 2015 Jul;144(1):1-11. doi: 10.1007/s00418-015-1319-1. Epub 2015 Apr 8.

2.

Genetic alterations of protein tyrosine phosphatases in human cancers.

Zhao S, Sedwick D, Wang Z.

Oncogene. 2015 Jul 23;34(30):3885-94. doi: 10.1038/onc.2014.326. Epub 2014 Sep 29. Review.

3.

Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis.

Craig SE, Brady-Kalnay SM.

Semin Cell Dev Biol. 2015 Jan;37:108-18. doi: 10.1016/j.semcdb.2014.09.004. Epub 2014 Sep 16. Review.

4.

A protease storm cleaves a cell-cell adhesion molecule in cancer: multiple proteases converge to regulate PTPmu in glioma cells.

Phillips-Mason PJ, Craig SE, Brady-Kalnay SM.

J Cell Biochem. 2014 Sep;115(9):1609-23. doi: 10.1002/jcb.24824.

5.

Protein tyrosine phosphatases--from housekeeping enzymes to master regulators of signal transduction.

Tonks NK.

FEBS J. 2013 Jan;280(2):346-78. doi: 10.1111/febs.12077. Epub 2013 Jan 17. Review.

6.

Single cell molecular recognition of migrating and invading tumor cells using a targeted fluorescent probe to receptor PTPmu.

Burden-Gulley SM, Qutaish MQ, Sullivant KE, Tan M, Craig SE, Basilion JP, Lu ZR, Wilson DL, Brady-Kalnay SM.

Int J Cancer. 2013 Apr 1;132(7):1624-32. doi: 10.1002/ijc.27838. Epub 2012 Oct 11.

7.

Receptor type protein tyrosine phosphatases (RPTPs) - roles in signal transduction and human disease.

Xu Y, Fisher GJ.

J Cell Commun Signal. 2012 Aug;6(3):125-38. doi: 10.1007/s12079-012-0171-5. Epub 2012 Aug 1.

8.

Receptor-type tyrosine phosphatase ligands: looking for the needle in the haystack.

Mohebiany AN, Nikolaienko RM, Bouyain S, Harroch S.

FEBS J. 2013 Jan;280(2):388-400. doi: 10.1111/j.1742-4658.2012.08653.x. Epub 2012 Jul 5. Review.

9.

Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo.

Kaur H, Burden-Gulley SM, Phillips-Mason PJ, Basilion JP, Sloan AE, Brady-Kalnay SM.

Neuro Oncol. 2012 May;14(5):561-73. doi: 10.1093/neuonc/nos066. Epub 2012 Apr 14.

10.

Diverse injurious stimuli reduce protein tyrosine phosphatase-μ expression and enhance epidermal growth factor receptor signaling in human airway epithelia.

Hyun SW, Anglin IE, Liu A, Yang S, Sorkin JD, Lillehoj E, Tonks NK, Passaniti A, Goldblum SE.

Exp Lung Res. 2011 Aug;37(6):327-43. doi: 10.3109/01902148.2011.566673. Epub 2011 Jun 7.

11.
12.

Characterization of the adhesive properties of the type IIb subfamily receptor protein tyrosine phosphatases.

Becka S, Zhang P, Craig SE, Lodowski DT, Wang Z, Brady-Kalnay SM.

Cell Commun Adhes. 2010 Apr;17(2):34-47. doi: 10.3109/15419061.2010.487957.

13.

Identification of phospholipase C gamma1 as a protein tyrosine phosphatase mu substrate that regulates cell migration.

Phillips-Mason PJ, Kaur H, Burden-Gulley SM, Craig SE, Brady-Kalnay SM.

J Cell Biochem. 2011 Jan;112(1):39-48. doi: 10.1002/jcb.22710.

14.

A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase mu.

Burden-Gulley SM, Gates TJ, Burgoyne AM, Cutter JL, Lodowski DT, Robinson S, Sloan AE, Miller RH, Basilion JP, Brady-Kalnay SM.

Neoplasia. 2010 Apr;12(4):305-16.

15.

Cancer-derived mutations in the fibronectin III repeats of PTPRT/PTPrho inhibit cell-cell aggregation.

Zhang P, Becka S, Craig SE, Lodowski DT, Brady-Kalnay SM, Wang Z.

Cell Commun Adhes. 2009 Dec;16(5-6):146-53. doi: 10.3109/15419061003653771.

16.

Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration.

Burgoyne AM, Phillips-Mason PJ, Burden-Gulley SM, Robinson S, Sloan AE, Miller RH, Brady-Kalnay SM.

Cancer Res. 2009 Sep 1;69(17):6960-8. doi: 10.1158/0008-5472.CAN-09-0863. Epub 2009 Aug 18.

17.

PTPmu suppresses glioma cell migration and dispersal.

Burgoyne AM, Palomo JM, Phillips-Mason PJ, Burden-Gulley SM, Major DL, Zaremba A, Robinson S, Sloan AE, Vogelbaum MA, Miller RH, Brady-Kalnay SM.

Neuro Oncol. 2009 Dec;11(6):767-78. doi: 10.1215/15228517-2009-019. Epub .

18.

BCCIP associates with the receptor protein tyrosine phosphatase PTPmu.

Phillips-Mason PJ, Mourton T, Major DL, Brady-Kalnay SM.

J Cell Biochem. 2008 Nov 1;105(4):1059-72. doi: 10.1002/jcb.21907.

19.

Tumor-derived extracellular mutations of PTPRT /PTPrho are defective in cell adhesion.

Yu J, Becka S, Zhang P, Zhang X, Brady-Kalnay SM, Wang Z.

Mol Cancer Res. 2008 Jul;6(7):1106-13. doi: 10.1158/1541-7786.MCR-07-2123.

20.

E-cadherin promotes retinal ganglion cell neurite outgrowth in a protein tyrosine phosphatase-mu-dependent manner.

Oblander SA, Ensslen-Craig SE, Longo FM, Brady-Kalnay SM.

Mol Cell Neurosci. 2007 Mar;34(3):481-92. Epub 2007 Feb 2.

Items per page

Supplemental Content

Write to the Help Desk